| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |